| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
6,247.30
|
|
Change (%)
|
595.65 (10.54%)
|
|
Best Buy (RS)
|
0(x0)
|
|
Best Sell (RS)
|
0(x0)
|
|
Today's Range (RS)
|
5,865.55
-
6,701.40
|
|
52-Week Range (RS)
|
4,699.70
-
6,701.40
|
|
Beta (1 Year)
|
0.37
|
|
|
|
|
|
| Index Details |
| BSE HC, BSE SmallCap |
| News |
|
Corporate Details |
| Procter & Gamble Health standalone net profit rises 54.63% in the March 2026 quarter |
| P&G Health soars after Q4 PAT jumps 54.63% YoY |
| Board of Procter & Gamble Health recommends final dividend |
| Jaiprakash Power Ventures Ltd leads gainers in 'A' group |
| Procter & Gamble Health to pay dividend |
| Board of Procter & Gamble Health recommends Interim Dividend |
| Board of Procter & Gamble Health recommends One-time Special Dividend |
| Procter & Gamble Health fixes record date for interim dividend |
| Procter & Gamble Health standalone net profit declines 14.64% in the December 2025 quarter |
| Procter & Gamble Health to declare Quarterly Results |
|
|
|
| Incoporation Year : 1967 |
| Chairman : S Madhavan |
| Ownership Group : MNC Associate |
| Sector : MAN |
| Industry : Pharmaceuticals - Multinational |
| Registered Office |
Procter & Gamble Health Ltd
Godrej One 8th Floor,
Projshanagar Vikhroli (East),
Mumbai,
Maharashtra-400079 |
Phone:91-22-62109000
Fax:91-22-62109999 |
| E-Mail : investorgrievance.im@pg.com |
| URL : http://www.pghealthindia.com |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
20-May-2026 |
5341.65 |
16.95 |
| 1Month |
27-Apr-2026 |
5176.55 |
20.68 |
| 3Month |
27-Feb-2026 |
4911.10 |
27.21 |
| 6Month |
27-Nov-2025 |
5771.70 |
8.24 |
| 1Year |
27-May-2025 |
5518.90 |
13.20 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| Nippon India Small Cap Fund |
0.50 |
362.40 |
| UTI-MNC Fund |
4.50 |
119.76 |
| ICICI Pru Smallcap Fund |
1.21 |
105.60 |
| DSP Healthcare Fund |
2.64 |
83.10 |
| Aditya Birla SL MNC Fund |
1.47 |
49.41 |
|
|
|
|
| Groups : Pharmaceuticals - Multinational |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Abbott India Ltd |
27,709.20 |
0.39 |
35,921.55 |
25,164.00 |
58,882.05 |
| Glaxosmithkline Pharmaceuticals Ltd |
2,301.05 |
0.78 |
3,515.95 |
2,218.00 |
38,981.18 |
| Astrazeneca Pharma India Ltd |
8,655.30 |
-3.66 |
10,653.05 |
7,630.00 |
21,638.25 |
| Pfizer Ltd |
4,624.85 |
-0.49 |
5,987.65 |
4,461.80 |
21,157.64 |
| Sanofi Consumer Healthcare India Ltd |
4,527.30 |
-2.49 |
5,954.00 |
3,950.50 |
10,426.65 |
|
|
|
|